In a diverse cohort of virologically suppressed women with HIV, long-acting cabotegravir and rilpivirine (CAB+RPV LA) maintained high rates of viral suppression with low virologic failure over a median...
Researchers evaluated the safety and efficacy of dolutegravir plus lamivudine in treatment-naive individuals with HIV without baseline resistance testing.
A multi-center study finds kidney transplantation from HIV-positive donors to HIV-positive recipients is as safe and effective as using kidneys from HIV-negative donors, offering new insights into expanding...
A clinical trial suggests semaglutide significantly reduces abdominal fat in HIV-associated lipohypertrophy, but the potential for adverse events warrant further investigation.
In a study that assessed pericoronary adipose tissue (PCAT) density, researchers noted an association between higher PCAT density and greater coronary plaque burden and cardiovascular disease in people with...
Researchers tested the impact of four different remotely delivered interventions and observed promising effects on several key health outcomes in patients over the age of 50 living with HIV.
A randomized clinical trial found that a nurse-led intervention strategy could improve systolic blood pressure and non-high-density lipoprotein cholesterol in patients with HIV, reducing their risk of...
Researchers conducted a randomized trial to evaluate the impact of mindfulness-based stress reduction on depression and quality of life in older adults living with HIV and cognitive impairment.
In a randomized clinical trial, researchers tested the efficacy of Skills to Manage Pain (STOMP), a behavioral intervention designed for people with HIV experiencing chronic pain. The study demonstrated...
